Courses

#103 Vitamin B6: Complex Biochemistry, Testing, Toxicity, and Appropriate Uses

Vitamin B6 has multiple mechanisms of action in humans. Additionally, its biochemistry is complex with multiple vitamers, all having potential effects in the body. Added to this complexity is the known effect of low B6 causing neuropathy, but also a bimodal “B6 toxicity state” where low or high levels of supplementation may trigger neuropathy as …

#103 Vitamin B6: Complex Biochemistry, Testing, Toxicity, and Appropriate Uses Read More »

#102 Neuroinflammation Causes and Interventions

Neuroinflammation is widespread in the chronic illness community. It is often known as part of the case, but the clinical nuances are often overlooked. In this CE we will discuss the triggers for neurological inflammation, underlying cause areas, and appropriate interventions. Relevant assessment, testing, interventions and pharmacology will be discussed.

#100 MCAS Part 2 – Mast Cell Activation to Mastocytosis Assessment & Therapy

Part 1 of this series went into histamine biology and management deeply. In this follow-up CE we will look more closely at the spectrum of mast cell disorders ranging from major pathologies in the mastocytosis family through all the functional mast cell activation syndromes. Causes, aggravations, therapies (natural and pharmacologic), and management will be addressed. …

#100 MCAS Part 2 – Mast Cell Activation to Mastocytosis Assessment & Therapy Read More »

#98 Toxicity and the GI Tract – Assessment & Therapies

While seemingly obvious, the issues of toxicant exposure and pathology in the GI tract are often overlooked. In this CE we will look at GI physiology affected by toxicants, exposure sources, the effect on microbiome and immune function, assessment, and natural and pharmacological therapies. Clinical management for both primary GI toxicity as well as secondary GI support …

#98 Toxicity and the GI Tract – Assessment & Therapies Read More »

#97 Multiple Sclerosis: Pharmacology and Integrative Case Management

Multiple Sclerosis is complex and can be difficult to manage medically. There are many potentiallydangerous comorbidities and proper diagnosis and management are critical. In addition to this, insome cases underlying pathology triggering the neurological autoimmune state may be assessedand treated. This case-based discussion of Multiple Sclerosis will discuss the pathogenesis,pharmacology, and assessment of underlying triggers.

#96 Graves Hyperthyroidism: Pharmacology and Integrative Case Management

Hyperthyroid states are often difficult to manage medically. There are many potentially dangerous comorbidities. In addition to this, in some cases underlying pathology triggering the hyperthyroidstate may be assessed and treated. This case-based discussion of Graves Hyperthyroidism willdiscuss the pathogenesis, pharmacology, and assessment of underlying triggers. Objectives:

#95 Cardiac Dysrhythmia: Pharmacology and Integrative Care Management

The topic of cardiac dysrhythmia can be a clinical conundrum when comorbid conditions intervene. Thediagnosis can become complex, and many times traditional drug therapies will not be completelyeffective. This CME is designed to review the pharmacology and mechanisms implicit in cardiacdysrhythmia. It is also designed to work through, by case analysis, a complex cardiac rhythmassessment …

#95 Cardiac Dysrhythmia: Pharmacology and Integrative Care Management Read More »

#94 The Microbiome and Cancer with a GI Cancer Update

An incredible amount of research has happened in the arena of the microbiome-immunome connection,specifically regarding cancer. In this CE we will discuss the data regarding the microbiome and cancerimmunology, how it may be applied in practice and what we still do not know. In addition we will discussan update regarding GI specific cancers.

#93 Cardiology Updates: Pathophysiology and Pharmacology

Regardless of the type of practice one has, there is a high frequency of cardiac comorbidity andpharmacology among patients. This webinar is designed to look at the functional/pathophysiologicalunderpinnings of cardiac issues as well as the detailed pharmacology used in cardiac care.

#91 GI Pharmacology – Infectious Disease

In this session Dr. Anderson will discuss pharmaceutical agents used in gastrointestinal infections. Attention to drugs covering bacterial, viral, fungal, parasitic and helminthic infections will be paid. OBJECTIVES:

#90 Oncology: Caring for People with Cancer Through the Four Phases of Cancer

In this session, Dr. Anderson will discuss how the evolution of cancer patient assessment has evolved in the past 30 years. How to look at the big picture of the patient case as well as the detail and how knowing what “phase” the cancer is in can help the clinician appropriately focus time and resources.

#88 Advanced Prostate Cancer

*Conundrums*Complications*Solutions* – My (IVC, Ozone etc…) Made my patients PSA go up. – They seem sicker with therapies that usually work. – Why don’t they react like lower stage PrCA? And on and on. In this CME Dr. Anderson will use not only his background primarily treating advanced prostate cancer cases but also his literature updates on …

#88 Advanced Prostate Cancer Read More »

#86 GI Cancer and Microbiome Considerations

We will discuss GI specific microbiome and cancer connections as well as specific cancer therapies. In this session Dr. Anderson will relate his experience and his review of the current data regarding the approach to GI cancers and their relationship to the microbiome. GI specific therapies and implementation will be discussed.

#85 Laboratory Medicine Series Part-6:

Laboratory medicine is a cornerstone of proper diagnosis and patient safety. This series is designed tobreak down the commonly used laboratory investigations in naturopathic and functional medicine.It will describe the tests in each category, discuss their meaning and define next steps to followwhen abnormalities are found.

#84 Laboratory Medicine Series Part-5 Hematology (Assessment Part-12)

Laboratory medicine is a cornerstone of proper diagnosis and patient safety. This series is designed to break down the commonly used laboratory investigations in naturopathic and functional medicine.It will describe the tests in each category, discuss their meaning and define next steps to follow when abnormalities are found.

#82 Laboratory Medicine Series Part-4 (Assessment Part-10)

Laboratory medicine is a cornerstone of proper diagnosis and patient safety. This series is designed to break down the commonly used laboratory investigations in naturopathic and functional medicine. It will describe the tests in each category, discuss their meaning and define next steps to follow when abnormalities are found.

#81 Lab Assessment Part-3 GI Lab Considerations

Laboratory medicine is a cornerstone of proper diagnosis and patient safety. This series is designed to break down the commonly used laboratory investigations in naturopathic and functional medicine. It will describe the tests in each category, discuss their meaning and define next steps to follow when abnormalities are found.

#80 Laboratory Assessment Part-2

In this webinar DrA will continue the lab assessment topics requested by subscribers. Our focus for this webinar will be pancreatic assessment, blood sugar assessment and “metabolic markers”.

#79 Laboratory Medicine Series: Part-1

Laboratory medicine is a cornerstone of proper diagnosis and patient safety. This series is designed to break down the commonly used laboratory investigations in naturopathic and functional medicine. It will describe the tests in each category, discuss their meaning and define next steps to follow when abnormalities are found.

#77 Cases in Neurochemistry

Neurochemistry is accessed daily in medicine by commonly used neuropsychiatric drug classes. In natural and integrative medicine, it is often confusing where to start with cases involving neurotransmitters and other factors due to overlap of signs and symptoms, concomitant medication use, and other issues. In this webinar Dr. Anderson will use his experience in thousands …

#77 Cases in Neurochemistry Read More »

#75 Immunology Part 5 Functional Immunology and Updates on TH1/2/17 Balance

Immunology is an ever-emerging part of biomedical science. In this session Dr. Anderson will update attendees regarding the Cell Mediated immune response, specifically where it concerns TH-1 and TH-2 effects, and their related immunology. The interrelationships between this portion of CMI and clinical medicine will be discussed.

#74 PharmPart-23 Vitamin C Use: Pharmacology, Safety, & Clinical Tips Q&A Part 2

The use of Vitamin C in integrative and Naturopathic medicine has a long history. The increase in use of newer forms such as liposomal oral products and wider use of IV Vitamin C has sparked a new group of clinical questions, safety and administration guidelines and general mechanism conundrums. This second installment CE is a …

#74 PharmPart-23 Vitamin C Use: Pharmacology, Safety, & Clinical Tips Q&A Part 2 Read More »

#72 – Biological Medicines

#72 – Biological Medicines: Clinical Tips, Considerations, and Integrations with natural medicines. CE 2.0 Total | 2.0 of which are Pharm Targeted biological therapies have in one way revolutionized some chronic GI diseases. In other ways they have complicated the landscape, monitoring and management of the GI patient. The positive and negative aspects of these …

#72 – Biological Medicines Read More »

Basic Science Boards

Basic Science Review Overview The current format includes a twenty-plus module series of presentations arranged in a case / organ / complaint format based on the clinical science format used by NABNE / NPLEX. Information based on learning content areas and seventeen years teaching and writing board exam questions will be given in the following …

Basic Science Boards Read More »

Clinical Science Boards

Clinical Science Review Overview The current format includes a twenty-plus module series of presentations arranged in a case / organ / complaint format based on the clinical science format used by NABNE / NPLEX. For each complaint / body system (Cardio, Neurology…) area the following topic areas will be focused on: Clinical and Physical Diagnosis …

Clinical Science Boards Read More »

#71 Post COVID Syndrome

#71 Post COVID Syndrome CE 2.0 Total | 1.0 of which are Pharm Post-COVID syndrome affects a portion of patients who have had COVID-19. The random nature of the signs and symptoms and their intensity are perplexing to clinicians trying to help these patients. In this CME Dr. Anderson will break down data from over …

#71 Post COVID Syndrome Read More »

#70 Toxins, Immune Function, and Cancer

#70 Toxins, Immune Function, and Cancer CE 2.0 Total | 1.o of which are Pharm Risk factors for cancer and proposed mechanisms: Metal toxins Chemical toxins Mycotoxins Testing and assessment: Therapeutic Strategies: In the preventive setting In the “secondary prevention” setting treating after cancer care to prevent recurrence Got a question? Head to the forum! …

#70 Toxins, Immune Function, and Cancer Read More »

#69 Injection Update IM and SQ

#69 Injection Update IM and SQ CE 2.0 Total | 2.0 of which are Pharm In this session Dr. Anderson will use his many decades injection experience to discuss customizing parenteral nutrient combinations and specific dosages for maximum efficacy. While this presentation will cover the pharmacology and administration of Vitamin, Mineral and Amino Acids it …

#69 Injection Update IM and SQ Read More »

#67 Immunology Part-4 Natural Immunologic Agents

#67 Immunology Part-4 Natural Immunologic Agents CE 2.0 Total | 2.0 of which are Pharm The plethora of new data regarding some natural immunologic agents is seemingly never ending. In this course we will specifically look at current data, testing and assessment and clinical factors in the use of common immunologic natural agents.

#66 Controversies in Oncology

#66 Controversies in Oncology CE 2.0 Total | 1.5 of which are Pharm Controversies (or maybe not) in Integrative Oncology: We hear “sound bites” saying ‘DON’T USE THIS IN CANCER PATIENTS’, or ‘THIS IS DANGEROUS’ etc. and are often confused. It becomes more confusing when the ‘experts’ will not all agree, and the treating physician …

#66 Controversies in Oncology Read More »

#43 Lab Testing for Vitamins B6, B12, and Folates

#43 Lab Testing for Vitamins B6, B12, and Folates CE 1.5 Total | 1.5 of which are Pharm Key concepts of Lab Testing for Vitamins B6, B12 and Folates are discussed in this webinar with Dr. Anderson.

#44 PHARM Part-15 Acute Use of Thyroid and Adrenal-RX

#44 PHARM Part-15 Acute Use of Thyroid and Adrenal-RX CE 2.0 Total | 2.0 of which are Pharm Key concepts of “Thyroid and Adrenal Therapies in the Acute or Chronic Illness Setting: Pharmacology, Management and Suppression” are discussed in this webinar with Dr. Anderson.

#47 USP-FDA Compounding Update

#47 USP-FDA Compounding Update CE 2.0 Total | 2.0 of which are Pharm Pharmacy, Office Compounding, and In Office Use update – Rule changes from the FDA/USP and their effects on your office compounding practices.

#42 PHARM Part-14 NAD Therapies

#42 PHARM Part-14 NAD Therapies CE 1.5 Total | 1.5 of which are Pharm Key concepts of NAD are discussed in this webinar with Dr. Anderson.

#31 Food Allergy and Sensitivity Syndromes

#31 Food Allergy and Sensitivity Syndromes CE 1.5 Total | 0.5 of which are Pharm Food Allergy and Sensitivity Syndromes Topic Outline: Immunology Food Allergy and Sensitivity Basics Types of Testing Implications of Testing Interventions and Monitoring

#33 Kidney and Liver Functions Lab and Clinical Effects

#33 Kidney and Liver Functions Lab and Clinical Effects CE 1.5 Total | 1.0 of which are Pharm Topic Outline: 1. Liver functions and clinical relevance Mechanisms Medications and supplements Clinical discussion 2. Kidney function and clinical relevance Mechanisms Medications and supplements Clinical discussion

#34 Organic Acid Testing (OAT) and Interpretation

#34 Organic Acid Testing (OAT) and Interpretation CE 1.5 Total | 0.5 of which are Pharm Topic Outline: WHAT ARE ORGANIC ACIDS? HOW ARE ORGANIC ACIDS ASSAYED FOR MEDICAL REASONS? HOW ARE ORGANIC ACIDS TESTS USED FOR PATHOLOGIC IMPORTANCE? INTERPRETATIONS

#32 HBOT-1 Hyperbaric Oxygen Therapies General

#32 HBOT-1 Hyperbaric Oxygen Therapies General CE 1.5 Total | 1.0 of which are Pharm Hyperbaric Oxygen Uses, Pharmacology and Management Topic Outline: What is HBOT Chamber Types / Pressures Prescription Parameters Neurological Considerations Oncology

#28 Immunology Part-1 Low Dose Naltrexone

#28 Immunology Part-1 Low Dose Naltrexone CE 1.5 Total | 1.5 of which are Pharm Overview: Basic pharmacology of Naltrexone Low versus High Dose Strategies Low Dose Mechanisms Clinical Uses Prescribing Guidelines Resources

#37 Detoxification Part-2 Fluoroquinolone Toxicity

#37 Detoxification Part-2 Fluoroquinolone Toxicity CE 1.5 Total | 1.5 of which are Pharm Treatment Considerations Fluoroquinolones (FQs) are among the most potent antimicrobial agents, which have seen their increasing use as human and veterinary medicines to control bacterial infections. FQs have been extensively found in surface water and municipal wastewaters, which has raised great …

#37 Detoxification Part-2 Fluoroquinolone Toxicity Read More »

#39 NEURO Part-2 Dysautonomia and EDS

#39 NEURO Part-2 Dysautonomia and EDS CE 1.5 Total | 0.5 of which are Pharm Key concepts in Dysautonomia and EDS discussed in this webinar with Dr. Anderson.

#36 PCOS

#36 PCOS CE 1.5 Total | 1.0 of which are Pharm PCOS – Assessment and Treatment Considerations Dr. Anderson discusses the PCOS, the history, and latest developments, as well as clinical observations.

#25 IV Injection Q&A Part-2

#25 IV Injection Q&A Part-2 CE 1.5 Total | 1.5 of which are Pharm An update regarding injection therapies, how the newer rules for compounding change things and time for questions. Part-1: Rules for compounding and handling Part-2: Injection therapy updates and clinical thinking

#24 Nutrigenomic Basics with Q&A

#24 Nutrigenomic Basics with Q&A CE 1.5 Total | 0.5 of which are Pharm A basic approach to nutrigenomics, how epigenetics interact and how to navigate treatment with patients.

#22 PHARM Part-9 Chronic Pain Medication Weaning

#22 PHARM Part-9 Chronic Pain Medication Weaning CE 1.5 Total | 1.5 of which are Pharm In this webinar, Dr. Anderson will discuss the basics of pain medication pharmacology and weaning from those medications. Assessment Therapy Management

#18 Autoimmunity Part-2 Case Management

#18 Autoimmunity Part-2 Case Management CE 1.5 Total | 0.5 of which are Pharm This webinar is a follow up to “Autoimmunity Part-1” expanding on cause areas and therapeutic options.

#17 PHARM Part-8 Respiratory Pharmacology Part-1 Prescription Management

#17 PHARM Part-8 Respiratory Pharmacology Part-1 Prescription Management CE 1.5 Total | 1.5 of which are Pharm In this webcall Dr. Anderson will describe the clinically relevant issues surrounding the choice of, dosing for and tapering off of steroid medications (including respiratory medications). How best to do it? How to use natural medications in the …

#17 PHARM Part-8 Respiratory Pharmacology Part-1 Prescription Management Read More »

#15 PHARM Part-6 Kidney Disease Management and Pharmacology

#15 PHARM Part-6 Kidney Disease Management and Pharmacology CE 1.5 Total | 1.5 of which are Pharm In this webcall Dr. Anderson will describe the clinically relevant issues surrounding dosing of substances (Oral and Injection / IV) in the “renally compromised” patient.  Additionally strategies for stabilizing and potentially healing the renal system will be discussed.  …

#15 PHARM Part-6 Kidney Disease Management and Pharmacology Read More »

#13 PHARM Part-5 Pediatric Dosing Strategies

Therapeutics, Organ System #13 PHARM Part-5 Pediatric Dosing Strategies CE 1.5 Total | 1.5 of which are Pharm In this webcall Dr. Anderson will describe the clinically relevant issues surrounding dose adjustments for pediatric patients. Calculation strategies, what matters most and clinical examples of Oral, IV and Injection therapies will be discussed.

Scroll to Top